| 27 Aug, 07:13 pm | — | … | Dr. Lal Path Labs Ltd. has informed the Exchange about General Updates | nse |
| 27 Aug, 07:11 pm | — | … | Dr. Lal PathLabs Ltd - 539524 - Announcement under Regulation 30 (LODR)-Updates on Acquisition | bse |
| 19 Aug, 06:25 pm | — | … | Incorporation of a Step-Down Subsidiary Company | nse |
| 30 Jul, 07:36 pm | — | … | Dr. Lal PathLabs Ltd - 539524 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript | bse |
| 30 Jul, 07:32 pm | — | … | Dr. Lal Path Labs Ltd. has informed the Exchange about Transcript | nse |
| 26 Jul, 08:08 pm | — | … | Dr. Lal PathLabs Ltd - 539524 - Announcement under Regulation 30 (LODR)-Change in Directorate | bse |
| 26 Jul, 08:01 pm | — | … | Dr. Lal Path Labs Ltd. has informed the Exchange regarding Change in Director(s) of the company. | nse |
| 24 Jul, 07:17 pm | — | … | Dr. Lal Path Labs Ltd. has informed the Exchange about Link of Recording | nse |
| 24 Jul, 07:13 pm | — | … | Dr. Lal PathLabs Ltd - 539524 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | bse |
| 24 Jul, 02:17 pm | — | … | Dr. Lal PathLabs Ltd - 539524 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 24 Jul, 02:15 pm | — | … | Dr. Lal Path Labs Ltd. has informed the Exchange about Investor Presentation | nse |
| 24 Jul, 02:14 pm | — | … | Dr. Lal PathLabs Ltd - 539524 - Announcement under Regulation 30 (LODR)-Investor Presentation | bse |
| 24 Jul, 02:11 pm | — | … | Dr. Lal Path Labs Ltd. has informed the Exchange regarding a press release dated July 24, 2026, titled "Press Release on Un-audited Financial Results (Standalone and Consolidated) for the Quarter ended June 30, 2026". | nse |
| 24 Jul, 01:57 pm | — | … | Dr. Lal PathLabs Ltd - 539524 - Corporate Action-Board approves Dividend | bse |
| 24 Jul, 01:51 pm | — | … | Dr. Lal PathLabs Ltd - 539524 - Announcement under Regulation 30 (LODR)-Acquisition | bse |
| 24 Jul, 01:49 pm | — | … | Dr. Lal PathLabs Ltd - 539524 - Grant Of Stock Options | bse |
| 24 Jul, 01:47 pm | — | … | Dr. Lal PathLabs Ltd - 539524 - The Record Date For The Purpose Of Payment Of Interim Dividend Shall Be July 30, 2026 | bse |
| 24 Jul, 01:45 pm | — | … | Dr. Lal Path Labs Ltd. has informed the Exchange about Acquisition(s) :1. Took note that the Board of Dr Lal PathLabs FZCO, Dubai, Wholly Owned Subsidiary of the Company, approved acquisition of stake in Sunshine Healthcare Limited ( SHL ), Ghana. 2. Took note that the Board of Dr. Lal Ventures Private Limited, Wholly Owned Subsidiary of the Company, approved acquisition of stake in Neuome Technologies Private Limited ( Neuome ). | nse |
| 24 Jul, 01:44 pm | — | … | Dr. Lal PathLabs Ltd - 539524 - Announcement under Regulation 30 (LODR)-Dividend Updates | bse |
| 24 Jul, 01:42 pm | — | … | Dr. Lal Path Labs Ltd. has informed the Exchange that Record date for the purpose of Dividend is 30-Jul-2026. | nse |
| 24 Jul, 01:41 pm | — | … | Dr. Lal Path Labs Ltd. has informed the Exchange regarding Outcome of Board Meeting held on July 24, 2026. | nse |
| 24 Jul, 01:40 pm | — | … | Dr. Lal Path Labs Ltd. has informed the Exchange that Board of Directors at its meeting held on July 24, 2026, declared Interim Dividend of Rs. 5 per equity share. | nse |
| 24 Jul, 01:39 pm | — | … | Dr. Lal PathLabs Ltd - 539524 - Un-Audited (Standalone & Consolidated) Financial Results Of The Company For The Quarter Ended June 30, 2026 | bse |
| 24 Jul, 01:37 pm | — | … | Dr. Lal Path Labs Ltd. has submitted to the Exchange, the financial results for the period ended Jun 30, 2026. | nse |
| 17 Jul, 07:40 pm | — | … | Dr. Lal Path Labs Ltd. has informed the Exchange about General Updates - Received an appellant order from Income Tax Department | nse |
| 17 Jul, 01:19 pm | — | … | Dr. Lal PathLabs Ltd - 539524 - Update on board meeting | bse |
| 17 Jul, 01:15 pm | — | … | Dr. Lal PathLabs Ltd - 539524 - Corporate Action-Board to consider Dividend | bse |
| 01 Jul, 07:59 pm | — | … | Dr. Lal Path Labs Ltd. has informed the Exchange regarding 'Letter Dispatched To The Members Of The Company- Weblink Of The Annual Report FY 2025-26'. | nse |
| 01 Jul, 01:26 pm | — | … | Dr. Lal PathLabs Ltd - 539524 - Reg. 34 (1) Annual Report. | bse |
| 01 Jul, 01:19 pm | — | … | Dr. Lal Path Labs Ltd. has informed the Exchange regarding 'Submission of Business Responsibility and Sustainability Report for the Financial Year 2025-26 ' | nse |
| 29 Jun, 12:28 pm | — | … | Dr. Lal PathLabs Ltd - 539524 - Board Meeting Intimation for Considering And Approving The Un-Audited (Standalone & Consolidated) Financial Results For The Quarter Ending June 30, 2026 | bse |
| 12 Jun, 08:32 pm | procedural | 0 | Dr. Lal Path Labs Ltd. updated the exchange on incorporation of a wholly owned subsidiary company. | nse |
| 06 May, 06:11 pm | — | … | Dr. Lal PathLabs Ltd - 539524 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript | bse |
| 06 May, 06:08 pm | — | … | Dr. Lal Path Labs Ltd. has informed the Exchange about Transcript | nse |
| 04 May, 10:55 pm | — | … | Dr. Vandana Lal has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. | nse |
| 04 May, 10:54 pm | — | … | Dr. Vandana Lal has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. | nse |
| 01 May, 07:18 pm | — | … | Dr. Lal PathLabs Ltd - 539524 - Announcement under Regulation 30 (LODR)-Updates on Acquisition | bse |
| 01 May, 07:17 pm | — | … | Dr. Lal Path Labs Ltd. has informed the Exchange about General Updates - Update on Acquisition | nse |
| 30 Apr, 07:09 pm | — | … | Dr. Lal PathLabs Ltd - 539524 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | bse |
| 30 Apr, 07:07 pm | — | … | Dr. Lal Path Labs Ltd. has informed the Exchange about Link of Recording | nse |
| 30 Apr, 04:10 pm | — | … | Dr. Lal PathLabs Ltd - 539524 - Announcement under Regulation 30 (LODR)-Investor Presentation | bse |
| 30 Apr, 04:09 pm | — | … | Dr. Lal Path Labs Ltd. has informed the Exchange about Investor Presentation | nse |
| 30 Apr, 04:07 pm | — | … | Dr. Lal PathLabs Ltd - 539524 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 30 Apr, 04:06 pm | — | … | Dr. Lal Path Labs Ltd. has informed the Exchange regarding a press release dated April 30, 2026, titled "Press Release on Audited Financial Results (Standalone and Consolidated) for the Quarter and Financial Year ended March 31, 2026". | nse |
| 30 Apr, 03:44 pm | — | … | Dr. Lal Path Labs Ltd. has informed the Exchange about re-appointment of Auditor(s):1. M/s Ernst & Young LLP (EY) as the Internal Auditors of the Company for the Financial Year 2026-27.2. M/s A.G. Agarwal & Associates as the Cost Auditors of the Company for the Financial Year 2026-27. | nse |
| 30 Apr, 03:43 pm | — | … | Dr. Lal Path Labs Ltd. has informed the Exchange about Senior Management Personnel | nse |
| 30 Apr, 03:41 pm | — | … | Dr. Lal Path Labs Ltd. has informed the Exchange about acquisition of 100% stake in Shahbazkers Diagnostic Centre Private Limited ( SDCPL ) from its existing Shareholders. Post acquisition, SDCPL shall become a Wholly Owned Subsidiary of the Company. | nse |
| 30 Apr, 03:39 pm | — | … | Dr. Lal Path Labs Ltd. has informed the Exchange about the incorporation of a Wholly Owned Subsidiary Company | nse |
| 30 Apr, 03:38 pm | — | … | Dr. Lal PathLabs Ltd - 539524 - Announcement under Regulation 30 (LODR)-Acquisition | bse |
| 30 Apr, 03:37 pm | — | … | Dr. Lal Path Labs Ltd. has informed the Exchange about Convening of 32nd Annual General Meeting (AGM) of the Company on Saturday, July 25, 2026, through Video Conferencing/ Other Audio-Visual Means (VC/ OAVM). | nse |